Non-Alcoholic Fatty Liver Disease, Heart Failure, and Long-Term Mortality: Insights From the National Health and Nutrition Examination Survey
- PMID: 35901855
- DOI: 10.1016/j.cpcardiol.2022.101333
Non-Alcoholic Fatty Liver Disease, Heart Failure, and Long-Term Mortality: Insights From the National Health and Nutrition Examination Survey
Abstract
To evaluate the association between non-alcoholic fatty liver disease (NAFLD), heart failure (HF), and all-cause mortality. Both NAFLD and HF are increasing in prevalence due to shared risk factors. We used data from the National Health and Nutrition Examination Survey (NHANES) 2005-2018 to identify non-pregnant individuals aged ≥20 years with HF and NAFLD and linked with the cause of death data from the National Center for Health Statistics. The associations between NAFLD, HF, and all-cause mortality were assessed using logistic regression and Cox proportional hazard modeling as appropriate. There were 82,358,893 weighted eligible participants of whom 3,833,667 (4.7%) had NAFLD. The mean (SE) age was 51.5 (0.35) years, 45.1% women, 63.0% Non-Hispanic White and 11.8% Non-Hispanic Black. Cardiovascular comorbidities were more common in participants with NAFLD; they were more likely to have hypertension (81.7% vs 53.5%), diabetes (65.1% vs 17.1%), stroke (7.3% vs 4.1%), coronary artery disease (14.9% vs 8.4%), or HF (10.5% v s 3.5%) compared with participants without NAFLD. In multivariate logistic regression models adjusting for age, race/ethnicity and sex, participants with NAFLD were 3.5 times more likely to have HF [aOR, 95% CI: 3.47 (1.98-6.06)]. Older age, male sex, presence of diabetes and coronary artery disease were associated with higher odds of HF in participants with established NAFLD. At the end of the follow-up period, participants with NAFLD had higher all-cause mortality compared with participants without NAFLD (HR [95% CI]: 1.93 [1.24-2.99], P < 0.001). In this analysis of US adults, ambulatory participants with NAFLD were ∼3.5 times more likely to have HF, and twice as likely to experience mortality compared with participants without NAFLD. Further studies are needed to identify the possible linkage between NAFLD and HF beyond the shared risk factor pathogenesis.
Copyright © 2022 Elsevier Inc. All rights reserved.
Similar articles
-
Disparities in heart failure between White, Black, and Hispanic young adults: insights from the National Health and Nutrition Examination Survey.Ther Adv Cardiovasc Dis. 2024 Jan-Dec;18:17539447241239814. doi: 10.1177/17539447241239814. Ther Adv Cardiovasc Dis. 2024. PMID: 38523335 Free PMC article.
-
Non-Alcoholic Fatty Liver Disease (NAFLD) and risk of new-onset heart failure: a retrospective analysis of 173,966 patients.Clin Res Cardiol. 2023 Oct;112(10):1446-1453. doi: 10.1007/s00392-023-02250-z. Epub 2023 Jul 6. Clin Res Cardiol. 2023. PMID: 37410163 Free PMC article.
-
Association between the liver fat score (LFS) and cardiovascular diseases in the national health and nutrition examination survey 1999-2016.Ann Med. 2021 Dec;53(1):1065-1073. doi: 10.1080/07853890.2021.1943514. Ann Med. 2021. PMID: 34184611 Free PMC article.
-
Non-alcoholic fatty liver disease is associated with a worse prognosis in patients with heart failure: A pool analysis.Front Endocrinol (Lausanne). 2023 Apr 20;14:1167608. doi: 10.3389/fendo.2023.1167608. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37152967 Free PMC article.
-
Non-Alcoholic Fatty Liver Disease as an Emerging Risk Factor for Heart Failure.Curr Heart Fail Rep. 2023 Aug;20(4):308-319. doi: 10.1007/s11897-023-00613-1. Epub 2023 Jul 4. Curr Heart Fail Rep. 2023. PMID: 37402108 Free PMC article. Review.
Cited by
-
The effects of supplementation of probiotics, prebiotics, or synbiotics on patients with non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials.Front Nutr. 2022 Oct 25;9:1024678. doi: 10.3389/fnut.2022.1024678. eCollection 2022. Front Nutr. 2022. PMID: 36386939 Free PMC article. Review.
-
Dietary Niacin Intake and Mortality Among Individuals With Nonalcoholic Fatty Liver Disease.JAMA Netw Open. 2024 Feb 5;7(2):e2354277. doi: 10.1001/jamanetworkopen.2023.54277. JAMA Netw Open. 2024. PMID: 38300619 Free PMC article.
-
Association between Dietary Niacin Intake and Nonalcoholic Fatty Liver Disease: NHANES 2003-2018.Nutrients. 2023 Sep 25;15(19):4128. doi: 10.3390/nu15194128. Nutrients. 2023. PMID: 37836412 Free PMC article.
-
Family income and cardiovascular disease risk in American adults.Sci Rep. 2023 Jan 6;13(1):279. doi: 10.1038/s41598-023-27474-x. Sci Rep. 2023. PMID: 36609674 Free PMC article.
-
Mechanisms Linking Metabolic-Associated Fatty Liver Disease (MAFLD) to Cardiovascular Disease.Curr Hypertens Rep. 2023 Aug;25(8):151-162. doi: 10.1007/s11906-023-01242-8. Epub 2023 May 16. Curr Hypertens Rep. 2023. PMID: 37191842 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous